Tobias S, Del Amo J, Albert S, Aubert M, Zerrari A, Chappard P, Ti L, Roux P Discordant drug checking results and risk reduction behaviours: findings from the ChecKnow study in France Drug Alcohol Rev PubMed
Wilson LA, Tobias S, Gandhi P, Nosyk B, Buxton JA, Ti L The comparative effects of prenatal exposure to methadone versus buprenorphine for opioid use disorder on neonatal outcomes: a systematic review and meta-analysis BMC Pregnancy Childbirth PubMed
Tobias S, Bird J, Guzman SM, Palis H, Crabtree A, Hein JE, Wood E, Ti L Temporal and regional associations between fentanyl concentrations in the unregulated drug supply and drug-related mortality in British Columbia, Canada Int J Drug Policy PubMed
Tobias S, Grant C, Lysyshyn M, Roux P, Wood E, Kerr T, Ti L Risk reduction behaviours following the detection of unexpected drugs through community drug checking: a cross-sectional study Harm Reduct J PubMed
Tobias S, Guzman SM, Hein JE, Ti L Development and validation of a fentanyl quantification model for drug checking services Drug Alcohol Depend Rep PubMed
Tobias S, Bird J, Law MR, Buxton JA, Ti L How population-level drug supply data are integrated into health outcomes research: a scoping review Epidemiol Rev PubMed
Tobias S, Tu A, Shapiro AM, Mérette SAM, Lysyshyn M, Wood E, Buxton JA, Ti L Fentanyl concentrations in unregulated opioids and the blood of drug toxicity decedents AJE Adv Link
Bird J, Tobias S, Grant C, Lysyshyn M, Tupper K, Wood E, Kerr T, Ti L Sharing drug checking results in a Canadian setting: a multi-site analysis Int J Drug Policy PubMed
Crepeault H, Tobias S, Angelucci J, Dubland S, Lysyshyn M, Wood E, Ti L Detection of benzodiazepines in the unregulated drug supply using point of care and confirmatory drug checking technologies: a validation study Drug Alcohol Depend PubMed
Tobias S, Angelucci J, Wood E, Buxton JA, Ti L Novel adulterants in unregulated opioids and their associations with adverse events Can J Public Health PubMed
